Bicara Therapeutics Inc. Common Stock

BCAX | NASDAQ

$22.01

-$0.63 (-2.78%)

At close: Sep 21, 2026, 4:00 PM ET

$22.01

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
Cash & Equivalents	96.69M	489.71M	230.44M	4.16M
Short-Term Investments	318.12M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	6.91M	6.62M	2.09M	1.08M
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	7.25M	12.82M	100K	68K
Total Current Assets	422.05M	502.53M	231.07M	4.98M
Property-Plant & Equipment	2.03M	845K	815K	636K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	8.94M	66.66M	2.91M	1.72M
Total Assets	430.99M	569.2M	233.98M	6.7M
Account Payables	7.79M	4.51M	3.19M	5.14M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	607K	n/a	n/a
Other Current Liabilities	5.04M	9.79M	1.74M	17.58M
Total Current Liabilities	28.95M	17.99M	15.09M	23.9M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	17K	85K
Total Long-Term Liabilities	593K	59.33M	389K	85K
Total Liabilities	29.54M	77.32M	15.47M	23.98M
Total Debt	1.71M	738K	657K	n/a
Book Value	401.45M	491.88M	218.51M	-17.28M
Book Value Per Share	7.34	9.04	4.22	-0.33
Common Stock	7K	7K	2K	2K
Retained Earnings	-358.97M	-221.02M	-153.02M	-101.04M
Comprehensive Income	243K	n/a	n/a	n/a
Shareholders Equity	401.45M	491.88M	218.51M	-17.28M
Total Investments	318.12M	n/a	n/a	n/a